Growth Hormone Deficiency
📧 Sign up to get email alerts when something new happens for Growth Hormone Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children [Phase 2]
Phase 2 study of long-acting growth hormone MOD-4023 in pediatric growth hormone deficiency completed with posted results.
-
FDA approval · 2020-01-08FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved Genotropin (somatropin) via a supplemental application submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA label_change · 2019-11-27FDA Approved: MACRILEN — Supplemental Application (Aeterna Zentaris GmbH)
The FDA is reviewing a supplemental application for MACRILEN (macimorelin acetate) by Aeterna Zentaris GmbH to update its labeling.
-
CLINICAL_TRIALS research · 2019-11-20Clinical Trial Update: A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients
Non-interventional, prospective study protocol assessing long-term outcomes of Genotropin treatment in growth hormone deficiency patients; c…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA) [Phase 2]
Phase 2 clinical trial update for MOD-4023 (long-lasting human growth hormone) in adults with growth hormone deficiency has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test. [Phase 3]
A Phase 3 trial investigating AEZS-130 as an oral growth hormone secretagogue for growth hormone stimulation testing in adults with growth h…
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: Observational Study of Somatropin Treatment in Children
Observational study update on somatropin (growth hormone) treatment in children, completed with results posted in 2019.
-
CLINICAL_TRIALS other · 2019-02-15Clinical Trial Update: Treatment of GHD Associated With CHF [Phase 3]
A Phase 3 clinical trial update on treatment of growth hormone deficiency associated with congestive heart failure is being conducted, spons…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. [Phase 4]
Phase 4 trial update evaluating ease of use, preference, and safety of EutropinPen Inject. in multiple pediatric indications.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children [Phase 1, Phase 2]
Clinical trial investigating free fatty acids, body weight, and growth hormone secretion in children; terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency [Phase 4]
Post-marketing Phase 4 study assessing immunogenicity of Nutropin AQ (somatropin) in children with growth hormone deficiency; results posted…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Saizen® E-Device User Trial [Phase 3]
Phase 3 trial evaluating Saizen's E-Device for growth disorders has been completed, with results posted in July 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Study of TV-1106 in Growth Hormone-Deficient Adults [Phase 3]
Phase 3 trial of TV-1106 in adults with growth hormone deficiency was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Growth Hormone and Endothelial Function in Children [Phase 4]
Phase 4 clinical trial update from Ohio State University examining the effect of growth hormone therapy on endothelial function in children …
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Anterior Pituitary Hormone Replacement in Traumatic Brain Injury [Phase 4]
This Phase 4 clinical trial update reports completion of a study on anterior pituitary hormone replacement in traumatic brain injury, with r…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Evalutation of Insulin Sensitivity Through Hyperinsulinemic Clamp in Children With GH Deficiency [NA]
A completed clinical trial assessed insulin sensitivity in children with growth hormone deficiency using a hyperinsulinemic clamp method. Th…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype
A completed clinical trial evaluating the effects of growth hormone supplementation on metabolism and adipose tissue molecular phenotype in …
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN® [Phase 4]
Phase 4 trial assessing predictive markers in children with growth hormone deficiency and Turner syndrome treated with SAIZEN. Results poste…
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Versartis Long-Term Safety Study of Somavaratan [Phase 2, Phase 3]
A long-term safety study of somavaratan (VRS-317) for pediatric growth hormone deficiency in Phase 2/Phase 3 has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency [Phase 3]
A Phase 3 long-term safety study of Somavaratan in Japanese children with growth hormone deficiency has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency [Phase 3]
Phase 3 validation study for macimorelin as a diagnostic test for adult growth hormone deficiency has completed; results were posted in 2018…
-
CLINICAL_TRIALS trial_result · 2018-02-08Clinical Trial Update: Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine [NA]
A completed clinical trial investigating an amino acid–based human growth hormone secretagogue for growth hormone-related treatment in aging…
-
FDA approval · 2018-01-30FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) by Ferring Pharmaceuticals. The action updates the product's indications o…
-
FDA approval · 2017-12-20FDA Approved: MACRILEN — Original Application (Aeterna Zentaris GmbH)
FDA approved MACRILEN (macimorelin acetate) from Aeterna Zentaris GmbH as an original application to diagnose adult growth hormone deficienc…
-
CLINICAL_TRIALS research · 2017-12-12Clinical Trial Update: Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children [Phase 4]
An extension study of pegylated somatropin in children with growth retardation due to endogenous growth hormone deficiency (Phase 4) is bein…